Pyridostigmine Bromide
- Product NDC
- 50268-638
- 11-digit product format
- 502680638
- Labeler code
- 50268
- Product ID
- 50268-638_910aaa4f-90ad-ec0b-e053-2995a90a8d05
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pyridostigmine Bromide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvPAK
- Application
- NDA009829
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2019-08-26
- Marketing end
- 0000-00-00
- Substance
- PYRIDOSTIGMINE BROMIDE
- Active strength
- 60 mg/1
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50268-638-15 | 50268063815 | 50 TABLET in 1 BOX (50268-638-15) | 50 tablet | 2019-08-26 | 0000-00-00 | No | No | Current |